{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T10:56:31Z","timestamp":1758970591228,"version":"3.44.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["75N91019F00130","75N910D00024"],"award-info":[{"award-number":["75N91019F00130","75N910D00024"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","award":["GS-US-540-5773","GS-US-540-5774"],"award-info":[{"award-number":["GS-US-540-5773","GS-US-540-5774"]}],"id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.mayocp.2020.06.016","type":"journal-article","created":{"date-parts":[[2020,6,20]],"date-time":"2020-06-20T13:59:30Z","timestamp":1592661570000},"page":"1946-1954","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Developing an Ethics Framework for Allocating Remdesivir in the COVID-19 Pandemic"],"prefix":"10.1016","volume":"95","author":[{"given":"Sarah","family":"Lim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debra A.","family":"DeBruin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathon P.","family":"Leider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nneka","family":"Sederstrom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Lynfield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason V.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Kline","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Kesler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stacey","family":"Rizza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard R.","family":"Sharp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan M.","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2020","series-title":"Letter to Ashley Rhoades","key":"10.1016\/j.mayocp.2020.06.016_bib1"},{"key":"10.1016\/j.mayocp.2020.06.016_bib2","unstructured":"Beigel JH, Tomashek KM, Dodd LE, et\u00a0al. Remdesivir for the treatment of Covid-19 -- preliminary report. N Engl J Med. Published online May 22, 2020. https:\/\/doi.org\/10.1056\/NEJMoa2007764. Available at: https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa2007764. Accessed May 22,\u00a02020."},{"key":"10.1016\/j.mayocp.2020.06.016_bib3","unstructured":"Goldman JD, Lye DCB, Hui DS, et\u00a0al. Remdesivir for 5 or 10 days in patients with severe Covid-19. N Engl J Med. Published online May 27, 2020. https:\/\/doi.org\/10.1056\/NEJMoa2015301. Available at: https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa2015301. Accessed May 27,\u00a02020."},{"key":"10.1016\/j.mayocp.2020.06.016_bib4","unstructured":"Eastman RT, Roth JS, Brimacombe KR, et\u00a0al. Remdesivir: a review of its discovery and development leading to emergency use authorization for treatment of COVID-19. ACS Cent Sci. 2020. Published online May 4, 2020. https:\/\/doi.org\/10.1021\/acscentsci.0c00489. Available at: https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acscentsci.0c00489. Accessed May 16,\u00a02020."},{"author":"Gilead","key":"10.1016\/j.mayocp.2020.06.016_bib5"},{"author":"Boodman","key":"10.1016\/j.mayocp.2020.06.016_bib7"},{"author":"University of Minnesota","key":"10.1016\/j.mayocp.2020.06.016_bib9"},{"year":"2010","series-title":"Implementing ethical frameworks for rationing scarce health resources in Minnesota during severe influenza pandemic. Final Report","author":"DeBruin","key":"10.1016\/j.mayocp.2020.06.016_bib14"},{"year":"2010","series-title":"For the good of us all:\u00a0ethically rationing health resources in Minnesota in a severe influenza pandemic.","author":"Vawter","key":"10.1016\/j.mayocp.2020.06.016_bib16"},{"author":"Colorado Department of Public Health and Environment","key":"10.1016\/j.mayocp.2020.06.016_bib17"},{"year":"2020","series-title":"Remdesivir use, receipt, and allocation in Virginia: frequently answered questions May 13, 2020","author":"Virginia Department of Health","key":"10.1016\/j.mayocp.2020.06.016_bib20"},{"year":"2020","series-title":"Experimental coronavirus drug remdesivir arrives in select Michigan hospitals","author":"Burns","key":"10.1016\/j.mayocp.2020.06.016_bib21"},{"year":"2020","series-title":"California Department of Public Health remdesivir distribution fact sheet","key":"10.1016\/j.mayocp.2020.06.016_bib22"},{"year":"2020","series-title":"COVID-19 treatment guidelines: potential antiviral drugs under evaluation for the treatment of COVID-19","key":"10.1016\/j.mayocp.2020.06.016_bib26"},{"issue":"10236","key":"10.1016\/j.mayocp.2020.06.016_bib27","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(20)31022-9","article-title":"Remdesivir in adults with\u00a0severe COVID-19: a randomized, double-blind, placebo-controlled, multicenter trial","volume":"395","author":"Wang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.mayocp.2020.06.016_bib28","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1056\/NEJMoa2007016","article-title":"Compassionate use of remdesivir for patients with severe COVID-19","volume":"382","author":"Grein","year":"2020","journal-title":"N\u00a0Engl J Med"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619620306200?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619620306200?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:33:15Z","timestamp":1758418395000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619620306200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":16,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S0025619620306200"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2020.06.016","relation":{},"ISSN":["0025-6196"],"issn-type":[{"type":"print","value":"0025-6196"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Developing an Ethics Framework for Allocating Remdesivir in the COVID-19 Pandemic","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2020.06.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Mayo Foundation for Medical Education and Research","name":"copyright","label":"Copyright"}]}}